Danny is a biopharma executive with over 20 years of experience in business development and corporate strategy, specializing in neuroscience and neurology. Holding both a PharmD from Northeastern University and an MBA from London Business School, he currently leads corporate development at PsychoGenics, focusing on partnerships and capital raising.
His recent professional focus has been on advancing innovative treatments for mental health and neuropsychiatric disorders across several companies. He actively promotes novel drug discovery technologies and seeks out investment and in-licensing opportunities to grow the CNS pipeline.
During his first week at PsychoGenics, the company announced an exclusive global license for an innovative compound to treat neuropsychiatric disorders.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.